Aducanumab approval: ‘We anticipate demand will be high’, says Alzheimer’s Association

The Alzheimer’s Association has welcomed the FDA’s approval of aducanumab for Alzheimer’s disease, calling it ‘the beginning of a completely new future for Alzheimer’s treatments’.